BARBIERI, Isaia
BARBIERI, Isaia
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten
2010-01-01 Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V.
Controlled masking and targeted release of redox-cycling ortho-quinones via a C–C bond-cleaving 1,6-elimination
2022-01-01 Dunsmore L.; Navo C.D.; Becher J.; de Montes E.G.; Guerreiro A.; Hoyt E.; Brown L.; Zelenay V.; Mikutis S.; Cooper J.; Barbieri I.; Lawrinowitz S.; Siouve E.; Martin E.; Ruivo P.R.; Rodrigues T.; da Cruz F.P.; Werz O.; Vassiliou G.; Ravn P.; Jimenez-Oses G.; Bernardes G.J.L.
Editorial: Roles of non-coding RNAs in tumor growth and development
2022-01-01 Sharma G.; Barbieri I.; Blandino G.; Poli V.; Siddiqui J.A.
From tissue invasion to glucose metabolism: the many aspects of Signal Transducer and Activator of Transcription 3 pro-oncogenic activities.
2012-01-01 S. Pensa; M. Demaria; L. Avalle; I. Barbieri; A. Camporeale; V. Poli.
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
2020-01-01 Prokoph N.; Probst N.A.; Lee L.C.; Monahan J.M.; Matthews J.D.; Liang H.-C.; Bahnsen K.; Montes-Mojarro I.A.; Karaca-Atabay E.; Sharma G.G.; Malik V.; Larose H.; Forde S.D.; Ducray S.P.; Lobello C.; Wang Q.; Luan S.-L.; Pospisilova S.; Gambacorti-Passerini C.; Burke G.A.A.; Pervez S.; Attarbaschi A.; Janikova A.; Pacquement H.; Landman-Parker J.; Lambilliotte A.; Schleiermacher G.; Klapper W.; Jauch R.; Woessmann W.; Vassal G.; Kenner L.; Merkel O.; Mologni L.; Chiarle R.; Brugieres L.; Geoerger B.; Barbieri I.; Turner S.D.
METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation
2019-01-01 Pandolfini L.; Barbieri I.; Bannister A.J.; Hendrick A.; Andrews B.; Webster N.; Murat P.; Mach P.; Brandi R.; Robson S.C.; Migliori V.; Alendar A.; d'Onofrio M.; Balasubramanian S.; Kouzarides T.
MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins
2017-01-01 Avalle, Lidia; Incarnato, Danny; Savino, Aurora; Gai, Marta; Marino, Francesca; Pensa, Sara; Barbieri, Isaia; Stadler, Michael B; Provero, Paolo; Oliviero, Salvatore; Poli, Valeria
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
2017-01-01 Barbieri I.; Tzelepis K.; Pandolfini L.; Shi J.; Millan-Zambrano G.; Robson S.C.; Aspris D.; Migliori V.; Bannister A.J.; Han N.; De Braekeleer E.; Ponstingl H.; Hendrick A.; Vakoc C.R.; Vassiliou G.S.; Kouzarides T.
RNA modifications detection by comparative Nanopore direct RNA sequencing
2021-01-01 Leger A.; Amaral P.P.; Pandolfini L.; Capitanchik C.; Capraro F.; Miano V.; Migliori V.; Toolan-Kerr P.; Sideri T.; Enright A.J.; Tzelepis K.; van Werven F.J.; Luscombe N.M.; Barbieri I.; Ule J.; Fitzgerald T.; Birney E.; Leonardi T.; Kouzarides T.
Role of RNA modifications in cancer
2020-01-01 Barbieri I.; Kouzarides T.
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
2018-01-01 Tzelepis K.; De Braekeleer E.; Aspris D.; Barbieri I.; Vijayabaskar M.S.; Liu W.-H.; Gozdecka M.; Metzakopian E.; Toop H.D.; Dudek M.; Robson S.C.; Hermida-Prado F.; Yang Y.H.; Babaei-Jadidi R.; Garyfallos D.A.; Ponstingl H.; Dias J.M.L.; Gallipoli P.; Seiler M.; Buonamici S.; Vick B.; Bannister A.J.; Rad R.; Prinjha R.K.; Marioni J.C.; Huntly B.; Batson J.; Morris J.C.; Pina C.; Bradley A.; Jeremias I.; Bates D.O.; Yusa K.; Kouzarides T.; Vassiliou G.S.
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene
2010-01-01 Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V.
The non-coding epitranscriptome in cancer
2021-01-01 Miano V.; Codino A.; Pandolfini L.; Barbieri I.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten | 2010 | Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V. | |
| Controlled masking and targeted release of redox-cycling ortho-quinones via a C–C bond-cleaving 1,6-elimination | 2022 | Dunsmore L.; Navo C.D.; Becher J.; de Montes E.G.; Guerreiro A.; Hoyt E.; Brown L.; Zelenay V.; Mikutis S.; Cooper J.; Barbieri I.; Lawrinowitz S.; Siouve E.; Martin E.; Ruivo P.R.; Rodrigues T.; da Cruz F.P.; Werz O.; Vassiliou G.; Ravn P.; Jimenez-Oses G.; Bernardes G.J.L. | |
| Editorial: Roles of non-coding RNAs in tumor growth and development | 2022 | Sharma G.; Barbieri I.; Blandino G.; Poli V.; Siddiqui J.A. | |
| From tissue invasion to glucose metabolism: the many aspects of Signal Transducer and Activator of Transcription 3 pro-oncogenic activities. | 2012 | S. Pensa; M. Demaria; L. Avalle; I. Barbieri; A. Camporeale; V. Poli. | |
| IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma | 2020 | Prokoph N.; Probst N.A.; Lee L.C.; Monahan J.M.; Matthews J.D.; Liang H.-C.; Bahnsen K.; Montes-Mojarro I.A.; Karaca-Atabay E.; Sharma G.G.; Malik V.; Larose H.; Forde S.D.; Ducray S.P.; Lobello C.; Wang Q.; Luan S.-L.; Pospisilova S.; Gambacorti-Passerini C.; Burke G.A.A.; Pervez S.; Attarbaschi A.; Janikova A.; Pacquement H.; Landman-Parker J.; Lambilliotte A.; Schleiermacher G.; Klapper W.; Jauch R.; Woessmann W.; Vassal G.; Kenner L.; Merkel O.; Mologni L.; Chiarle R.; Brugieres L.; Geoerger B.; Barbieri I.; Turner S.D. | |
| METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation | 2019 | Pandolfini L.; Barbieri I.; Bannister A.J.; Hendrick A.; Andrews B.; Webster N.; Murat P.; Mach P.; Brandi R.; Robson S.C.; Migliori V.; Alendar A.; d'Onofrio M.; Balasubramanian S.; Kouzarides T. | |
| MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins | 2017 | Avalle, Lidia; Incarnato, Danny; Savino, Aurora; Gai, Marta; Marino, Francesca; Pensa, Sara; Barbieri, Isaia; Stadler, Michael B; Provero, Paolo; Oliviero, Salvatore; Poli, Valeria | |
| Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control | 2017 | Barbieri I.; Tzelepis K.; Pandolfini L.; Shi J.; Millan-Zambrano G.; Robson S.C.; Aspris D.; Migliori V.; Bannister A.J.; Han N.; De Braekeleer E.; Ponstingl H.; Hendrick A.; Vakoc C.R.; Vassiliou G.S.; Kouzarides T. | |
| RNA modifications detection by comparative Nanopore direct RNA sequencing | 2021 | Leger A.; Amaral P.P.; Pandolfini L.; Capitanchik C.; Capraro F.; Miano V.; Migliori V.; Toolan-Kerr P.; Sideri T.; Enright A.J.; Tzelepis K.; van Werven F.J.; Luscombe N.M.; Barbieri I.; Ule J.; Fitzgerald T.; Birney E.; Leonardi T.; Kouzarides T. | |
| Role of RNA modifications in cancer | 2020 | Barbieri I.; Kouzarides T. | |
| SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4 | 2018 | Tzelepis K.; De Braekeleer E.; Aspris D.; Barbieri I.; Vijayabaskar M.S.; Liu W.-H.; Gozdecka M.; Metzakopian E.; Toop H.D.; Dudek M.; Robson S.C.; Hermida-Prado F.; Yang Y.H.; Babaei-Jadidi R.; Garyfallos D.A.; Ponstingl H.; Dias J.M.L.; Gallipoli P.; Seiler M.; Buonamici S.; Vick B.; Bannister A.J.; Rad R.; Prinjha R.K.; Marioni J.C.; Huntly B.; Batson J.; Morris J.C.; Pina C.; Bradley A.; Jeremias I.; Bates D.O.; Yusa K.; Kouzarides T.; Vassiliou G.S. | |
| Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene | 2010 | Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V. | |
| The non-coding epitranscriptome in cancer | 2021 | Miano V.; Codino A.; Pandolfini L.; Barbieri I. |